- Home
- BOLD vs FCUV Comparison
BOLD vs FCUV Comparison
Compare BOLD & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- FCUV
- Stock Information
- Founded
- BOLD 2018
- FCUV 2012
- Country
- BOLD United States
- FCUV United States
- Employees
- BOLD N/A
- FCUV N/A
- Industry
- BOLD
- FCUV Industrial Machinery/Components
- Sector
- BOLD
- FCUV Industrials
- Exchange
- BOLD Nasdaq
- FCUV Nasdaq
- Market Cap
- BOLD 24.4M
- FCUV 27.6M
- IPO Year
- BOLD 2024
- FCUV N/A
- Fundamental
- Price
- BOLD $1.19
- FCUV $2.57
- Analyst Decision
- BOLD Buy
- FCUV
- Analyst Count
- BOLD 3
- FCUV 0
- Target Price
- BOLD $4.00
- FCUV N/A
- AVG Volume (30 Days)
- BOLD 105.1K
- FCUV 20.4K
- Earning Date
- BOLD 08-11-2025
- FCUV 08-13-2025
- Dividend Yield
- BOLD N/A
- FCUV N/A
- EPS Growth
- BOLD N/A
- FCUV N/A
- EPS
- BOLD N/A
- FCUV N/A
- Revenue
- BOLD N/A
- FCUV $408,887.00
- Revenue This Year
- BOLD N/A
- FCUV N/A
- Revenue Next Year
- BOLD N/A
- FCUV N/A
- P/E Ratio
- BOLD N/A
- FCUV N/A
- Revenue Growth
- BOLD N/A
- FCUV 6.49
- 52 Week Low
- BOLD $1.00
- FCUV $1.50
- 52 Week High
- BOLD $4.72
- FCUV $10.90
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- FCUV 27.18
- Support Level
- BOLD N/A
- FCUV $2.68
- Resistance Level
- BOLD N/A
- FCUV $2.99
- Average True Range (ATR)
- BOLD 0.00
- FCUV 0.31
- MACD
- BOLD 0.00
- FCUV -0.06
- Stochastic Oscillator
- BOLD 0.00
- FCUV 9.25
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About FCUV Focus Universal Inc.
Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.